METASTATIC NSCLC
Clinical trials for METASTATIC NSCLC explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NSCLC trials appear
Sign up with your email to follow new studies for METASTATIC NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost immune attack on hard-to-treat cancers
Disease control OngoingThis early-phase study tests a new drug called NBTXR3, which is injected into tumors and activated by radiation. It is combined with an immunotherapy (anti-PD-1) to see if it can help the immune system fight advanced cancers better. About 145 adults with various advanced solid tu…
Matched conditions: METASTATIC NSCLC
Phase: PHASE1 • Sponsor: Nanobiotix • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
Blood test may predict immunotherapy success in lung and Head/Neck cancers
Knowledge-focused OngoingThis study looks at how well immunotherapy works in patients with advanced lung or head/neck cancer. Researchers will measure how fast the drug leaves the body and track tumor cells in the blood. The goal is to find better ways to predict which patients will benefit from treatmen…
Matched conditions: METASTATIC NSCLC
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 17, 2026 00:45 UTC